Latin America Sets Sights On Creating New Regional Medicines Regulator

Centralized Marketing Authorization Should Be Priority, Says Industry

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

Regulators in Mexico, Colombia and Cuba have affirmed plans to create a new Latin American and Caribbean Medicines Agency.

Global manufacturing network
Latin America and the Caribbean Could Look To Europe To Create New Regional Regulator • Source: Shutterstock

Mexico, Colombia and Cuba, are moving ahead with plans to create a new Latin American and Caribbean Medicines Agency that would work towards regulatory convergence as a means of improving access to medicines and stimulating innovation, said regulators from the three countries. The pharmaceutical industry is in support of a new agency and says it would like to see a new regional body follow in the model of the European Medicines Agency.

Cofepris, Invima and Cecmed, the respective regulatory agencies from Mexico, Colombia and Cuba, made the announcement in a recent statement...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Latin America

Brazil Issues Guidance On Regulatory Reliance & Equivalent Authorities

 
• By Francesca Bruce

Brazilian regulator Anvisa is relying on the decisions of its foreign counterparts as a means of ensuring more quality medicines are made available in the country.

Anvisa To Access US FDA-Reviewed Data For More Robust Evaluations In Brazil

 
• By Francesca Bruce

Brazil has also published its recent regulatory reliance regulations in English, a move designed to increase confidence in its decisions as it presses on with aligning its national practices with global best practices.

Colombia Signs Agreement With PAHO To Strengthen Regulatory Capacity

 
• By Francesca Bruce

The deal comes at a time when Latin American countries are increasingly looking to improve the regulatory environment for pharmaceuticals and move towards greater convergence.

Mexico Launches ‘Regulatory Certainty Strategy’ For Biosimilars

 
• By Francesca Bruce

Mexico is to establish a new regulatory framework that is in line with international standards to encourage domestic production of biosimilar medicines. 

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description

Diversity Action Plans: What To Submit And When

 
• By Nielsen Hobbs

With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.